These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 28665463)
1. Port in oncology practice: 3-monthly locking with normal saline for catheter maintenance, a preliminary report. Solinas G; Platini F; Trivellato M; Rigo C; Alabiso O; Galetto AS J Vasc Access; 2017 Jul; 18(4):325-327. PubMed ID: 28665463 [TBL] [Abstract][Full Text] [Related]
2. A comparison of infections and complications in central venous catheters in adults with solid tumours. Coady K; Ali M; Sidloff D; Kenningham RR; Ahmed S J Vasc Access; 2015; 16(1):38-41. PubMed ID: 25198809 [TBL] [Abstract][Full Text] [Related]
3. Central line bundle for prevention of central line-associated bloodstream infection for totally implantable venous access devices (ports) in pediatric cancer patients. Devrim İ; Oruç Y; Demirağ B; Kara A; Düzgöl M; Uslu S; Yaşar N; Aydın Köker S; Töret E; Bayram N; Vergin C J Vasc Access; 2018 Jul; 19(4):358-365. PubMed ID: 29926785 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients. Bertoglio S; Solari N; Meszaros P; Vassallo F; Bonvento M; Pastorino S; Bruzzi P Cancer Nurs; 2012; 35(4):E35-42. PubMed ID: 22228390 [TBL] [Abstract][Full Text] [Related]
5. Implantation of central venous ports with catheter insertion via the right internal jugular vein in oncology patients: single center experience. Charvát J; Linke Z; Horáèková M; Prausová J Support Care Cancer; 2006 Nov; 14(11):1162-5. PubMed ID: 16596418 [TBL] [Abstract][Full Text] [Related]
6. Peripherally inserted central catheters in the treatment of children with cancer: Results of a multicenter study. Rykov MY; Zaborovskij SV; Shvecov AN; Shukin VV J Vasc Access; 2018 Jul; 19(4):378-381. PubMed ID: 29546772 [TBL] [Abstract][Full Text] [Related]
7. Fractures of totally implantable central venous ports: more than fortuity. A three-year single center experience. Balsorano P; Galducci G; De Fanti I; Evans SK; De Gaudio AR; Pelagatti C J Vasc Access; 2014; 15(5):391-5. PubMed ID: 25041921 [TBL] [Abstract][Full Text] [Related]
8. Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial. Taxbro K; Hammarskjöld F; Thelin B; Lewin F; Hagman H; Hanberger H; Berg S Br J Anaesth; 2019 Jun; 122(6):734-741. PubMed ID: 31005243 [TBL] [Abstract][Full Text] [Related]
9. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device. Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441 [TBL] [Abstract][Full Text] [Related]
10. Peripherally inserted central catheter-related complications in cancer patients: a prospective study of over 50,000 catheter days. Kang J; Chen W; Sun W; Ge R; Li H; Ma E; Su Q; Cheng F; Hong J; Zhang Y; Lei C; Wang X; Jin A; Liu W J Vasc Access; 2017 Mar; 18(2):153-157. PubMed ID: 28218366 [TBL] [Abstract][Full Text] [Related]
11. Comparison of two types of catheters through femoral vein catheterization in patients with lung cancer undergoing chemotherapy: A retrospective study. Xu B; Zhang J; Tang S; Hou J; Ma M J Vasc Access; 2018 Nov; 19(6):651-657. PubMed ID: 29701120 [TBL] [Abstract][Full Text] [Related]
12. Mechanical recanalization for clot occlusion of venous access ports: experimental study using ports with clot occlusion. Song MG; Seo TS; Kim BH; Kim JH J Vasc Access; 2017 Mar; 18(2):158-162. PubMed ID: 28218362 [TBL] [Abstract][Full Text] [Related]
13. Implanting totally implantable venous access ports in the upper arm is feasible and safe for patients with early breast cancer. Xu H; Chen R; Jiang C; You S; Zhu Q; Li Y; Li S; Zha X; Wang J J Vasc Access; 2020 Sep; 21(5):609-614. PubMed ID: 31841061 [TBL] [Abstract][Full Text] [Related]
14. Direct translumbar inferior vena cava ports for long-term central venous access in patients with cancer. Butros SR; Walker TG; Salazar GM; Kalva SP; Oklu R; Wicky S; Ganguli S J Vasc Interv Radiol; 2014 Apr; 25(4):556-60. PubMed ID: 24507994 [TBL] [Abstract][Full Text] [Related]
15. Severe Neutropenia at the Time of Implantable Subcutaneous Chest Port Insertion Is Not a Risk Factor for Port Removal at a Tertiary Pediatric Center. Hoss DR; Bedros AA; Mesipam A; Criddle J; Smith JC J Vasc Interv Radiol; 2017 Mar; 28(3):398-402. PubMed ID: 28034702 [TBL] [Abstract][Full Text] [Related]
16. Effect of catheter diameter on left innominate vein in breast cancer patients after totally implantable venous access port placement. Song MG; Seo TS; Kim YH; Cho SB; Chung HH; Lee SH; Jung E J Vasc Access; 2018 Nov; 19(6):615-619. PubMed ID: 29560786 [TBL] [Abstract][Full Text] [Related]
17. A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute. Mori Y; Nagayama S; Kawamura J; Hasegawa S; Tanaka E; Okabe H; Takeuchi M; Sonobe M; Matsumoto S; Kanai M; Muto M; Chiba T; Sakai Y Int J Clin Oncol; 2016 Jun; 21(3):474-82. PubMed ID: 26507141 [TBL] [Abstract][Full Text] [Related]
18. A prospective, randomized comparison of three different types of valved and non-valved peripherally inserted central catheters. Pittiruti M; Emoli A; Porta P; Marche B; DeAngelis R; Scoppettuolo G J Vasc Access; 2014; 15(6):519-23. PubMed ID: 25198813 [TBL] [Abstract][Full Text] [Related]
19. Infection of totally implantable venous access devices: A review of the literature. Pinelli F; Cecero E; Degl'Innocenti D; Selmi V; Giua R; Villa G; Chelazzi C; Romagnoli S; Pittiruti M J Vasc Access; 2018 May; 19(3):230-242. PubMed ID: 29512430 [TBL] [Abstract][Full Text] [Related]
20. Retrospective evaluation of totally implantable venous access port devices: early and late complications. Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D J BUON; 2015; 20(1):338-45. PubMed ID: 25778336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]